Met Life Investment Management, LLC Accolade, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Accolade, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 43,337 shares of ACCD stock, worth $300,325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,337
Previous 37,069
16.91%
Holding current value
$300,325
Previous $142,000
4.23%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding ACCD
# of Institutions
172Shares Held
62.4MCall Options Held
27.3KPut Options Held
1.36M-
Black Rock Inc. New York, NY6.16MShares$42.7 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.66MShares$32.3 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.18MShares$29 Million0.0% of portfolio
-
Ah Equity Partners Iv (Parallel), L.L.C. Menlo Park, CA3.78MShares$26.2 Million88.81% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.48MShares$24.1 Million0.29% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $499M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...